Charles Pope Net Worth

The estimated Net Worth of Charles L Pope is at least $119 Thousand dollars as of 31 March 2018. Mr. Pope owns over 23,256 units of Oragenics Inc stock worth over $88,152 and over the last 15 years he sold OGEN stock worth over $31,100. In addition, he makes $0 as Independent Director at Oragenics Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Pope OGEN stock SEC Form 4 insiders trading

Charles has made over 16 trades of the Oragenics Inc stock since 2009, according to the Form 4 filled with the SEC. Most recently he exercised 23,256 units of OGEN stock worth $11,628 on 31 March 2018.

The largest trade he's ever made was buying 100,000 units of Oragenics Inc stock on 28 December 2009 worth over $25,000. On average, Charles trades about 6,218 units every 74 days since 2009. As of 31 March 2018 he still owns at least 176,304 units of Oragenics Inc stock.

You can see the complete history of Mr. Pope stock trades at the bottom of the page.

Charles Pope biography

Charles L. Pope, CPA, is an Independent Director of ORAGENICS, INC. Mr. Pope currently serves as a Director since June 2010. Mr. Pope served as the Chief Financial Officer of Palm Bancorp, Inc. from June 2009 to June 2012. From September 2007 through June 2009, Mr. Pope served as the Chief Financial Officer of Aerosonic Inc., a manufacturer of aviation products. Mr. Pope served as the Chief Financial Officer of Reptron Inc., a manufacturer of electronic products, from March 2005 through June 2007. From March 2002 to March 2005, Mr. Pope served as Chief Financial Officer of SRI/Surgical Express, Inc. From February 2001 to March 2002 Mr. Pope served as Chief Financial Officer of Innovaro, Inc. (formerly UTEK Corporation OTC BB:INNI) a public company. Mr. Pope served as a director of Innovaro, Inc. from March 2010 to August 2012. He has also served as a director of Inuvo, Inc. (NYSE MKT: INUV) since 2008. Inuvo is a public company, specialized in marketing browser – based consumer applications, managing networks of website publishers and operating specialty websites). Prior to this time, Mr. Pope served as a Partner in the Audit and Financial Advisory Consulting Divisions and was a Partner in the Accounting and SEC Directorate at PricewaterhouseCoopers LLP. Mr. Pope holds a B.S. degree in Economics and Accounting from Auburn University and is a Certified Public Accountant in Florida.

How old is Charles Pope?

Charles Pope is 66, he's been the Independent Director of Oragenics Inc since 2010. There are 1 older and 7 younger executives at Oragenics Inc. The oldest executive at Oragenics Inc is Dr. Frederick W. Telling Ph.D., 69, who is the Exec. Chairman.

What's Charles Pope's mailing address?

Charles's mailing address filed with the SEC is 4902 EISENHOWER BOULEVARD, , TAMPA, FL, 33634.

Insiders trading at Oragenics Inc

Over the last 12 years, insiders at Oragenics Inc have traded over $5,827,684 worth of Oragenics Inc stock and bought 8,095,027 units worth $13,189,855 . The most active insiders traders include Randal Jintrexon Corp Kirk, Joseph Hernandez, and Robert C Koski. On average, Oragenics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $151,398. The most recent stock trade was executed by Fred Telling on 30 November 2023, trading 3,500 units of OGEN stock currently worth $12,495.

What does Oragenics Inc do?

oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies. offerings are based on the probiora3 technology and brands include evoraplus™ is a new, one-of-a-kind probiotic mint that naturally supports gum and tooth health while freshening breath and whitening teeth. oragenics has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, in diagnostics, and in oral health.

Complete history of Mr. Pope stock trades at Inuvo Inc, Oragenics Inc, and Trxade Health Inc

Oragenics Inc executives and stock owners

Oragenics Inc executives and other stock owners filed with the SEC include:

• Michael O. Sullivan CPA,
  CFO, Sec., Treasurer & Interim Principal Exec. Officer
• Dr. Martin Handfield M.Sc., Ph.D.,
  Sr. VP of Discovery Research
• Michael Sullivan,
  Chief Financial Officer, Treasurer, Secretary
• Dr. Frederick W. Telling Ph.D.,
  Exec. Chairman
• Charles Pope,
  Independent Director
• Robert Koski,
  Independent Director
• Alan Dunton,
  Independent Director
• Kim Murphy,
  Director
• Alan Joslyn,
  President, Chief Executive Officer, Director
• Frederick Telling,
  Independent Chairman of the Board
• Dr. Raman Bedi,
  Chairman of International Scientific Advisory Board and Sr. Consultant
• Joseph Hernandez,
  10% owner
• John P Gandolfo,
  Director
• Bruce A. Sr. Cassidy,
  Director
• Randal Jintrexon Corp Kirk,
  
• Fred Telling,
  Director
• Family Lpkoski Robert Ckosk...,
  
• Janet Huffman,
  CFO, Secretary and Treasurer
• Christine L Koski,
  
• Family Lp Koski,
  
• Thomas L Koski,
  
• Beverly Koski,
  
• Robert Ckoski Christine Lko...,
  
• Family Lpkoski Christine Lk...,
  
• John N Bonfiglio,
  President and CEO
• Family Lpkoski Beverlykoski...,
  
• J Michael Redmond,
  President
• Robert C Koski,
  Director